|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.252
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.235
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.186
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.184
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.177
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.168
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.151
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.138
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.129
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.129
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.106
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.104
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.099
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.098
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.089
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.087
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.084
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.079
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.073
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.068
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.068
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.067
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.067
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.067
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.066
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.065
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.065
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.063
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.063
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.062
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.062
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.061
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.060
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.059
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.059
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.058
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.058
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.056
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.056
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.055
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.053
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.052
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.051
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.049
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.048
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.047
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.047
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.046
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.046
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.046
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.045
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.045
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.045
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.045
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.045
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.044
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.044
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.043
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.042
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.041
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.040
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.040
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.040
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.040
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.040
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.039
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.039
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.039
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.039
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.039
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.039
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.038
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.038
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.038
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.038
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.038
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.037
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.037
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.037
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.037
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.036
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.036
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.036
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.036
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.036
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.036
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.036
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.035
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.035
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.034
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.034
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.034
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.034
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.033
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.033
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.033
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.032
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.032
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.032
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.032
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.032
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.032
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.031
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.031
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.031
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.031
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.031
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.030
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.030
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.030
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.030
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.029
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.029
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.029
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.029
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.029
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.029
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.028
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.028
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.028
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.028
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.028
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.028
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.028
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.027
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.027
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.027
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.027
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.027
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.027
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.027
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.026
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.026
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.026
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.026
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.026
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.026
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.026
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.026
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.026
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.026
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.026
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.026
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.025
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.025
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.025
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.025
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.025
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.025
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.025
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.025
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.025
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.025
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.025
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.024
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.024
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.024
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.024
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
44 |
0.024
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.024
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.024
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.023
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.023
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.023
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.023
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.023
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.023
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.023
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.023
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.022
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.022
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.022
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.022
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.022
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.022
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.022
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.022
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.022
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.022
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.022
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.021
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.021
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.021
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.021
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.021
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.021
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.021
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.021
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.021
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.021
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.021
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.020
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.020
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.020
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.020
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.020
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.020
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.020
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.020
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.020
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.020
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.020
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.020
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.020
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.020
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.019
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.019
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.019
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.019
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.019
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.019
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.019
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.019
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.019
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.019
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.018
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.018
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.018
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.018
|
|
|
|
regulation of circadian sleep wake cycle rem sleep
|
GO:0042320 |
1 |
0.018
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.018
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.018
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.018
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.018
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.018
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.018
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.018
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.018
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.018
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.018
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.017
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.017
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.017
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.017
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.017
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.017
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.017
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.017
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.017
|
|
|
|
l alpha amino acid transmembrane transport
|
GO:1902475 |
23 |
0.017
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.017
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.017
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.017
|
|
|
|
response to ammonium ion
|
GO:0060359 |
21 |
0.017
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.017
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.016
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.016
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.016
|
|
|
|
negative regulation of iron ion transport
|
GO:0034757 |
1 |
0.016
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.016
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.016
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.016
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.016
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.016
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.016
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.016
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.016
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.016
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.016
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.016
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.016
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.016
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.016
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.016
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.016
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.016
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.016
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.016
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.015
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.015
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.015
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.015
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.015
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.015
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.015
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.015
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.015
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.015
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.015
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.015
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.015
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.015
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.015
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.015
|
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.015
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.015
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.015
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.015
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.015
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.014
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.014
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.014
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.014
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.014
|
|
|
|
positive regulation of immune complex clearance by monocytes and macrophages
|
GO:0090265 |
2 |
0.014
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.014
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.014
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.014
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.014
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.014
|
|
|
|
negative regulation of adenylate cyclase activity
|
GO:0007194 |
1 |
0.014
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.014
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.014
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.014
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.014
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.014
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.014
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
28 |
0.014
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.014
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.014
|
|
|
|
detection of mechanical stimulus involved in sensory perception of sound
|
GO:0050910 |
16 |
0.014
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.014
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.014
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.013
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.013
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.013
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.013
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.013
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.013
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.013
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.013
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.013
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.013
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.013
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.013
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.013
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.013
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.013
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.013
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.013
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.013
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.013
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.013
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.013
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.013
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.013
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.013
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.013
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.013
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.013
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.013
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.013
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.013
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.013
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.013
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.013
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.013
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.012
|
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.012
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.012
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.012
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.012
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.012
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.012
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.012
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.012
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.012
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.012
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.012
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.012
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.012
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.012
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.012
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.012
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.012
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.012
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.012
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.012
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.012
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.012
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.012
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.012
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.012
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.012
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.012
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.012
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.012
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.012
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.012
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.012
|
|
|
|
immune complex clearance
|
GO:0002434 |
2 |
0.012
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.012
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.012
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.012
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.012
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.011
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.011
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.011
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.011
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.011
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.011
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.011
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.011
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.011
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.011
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.011
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.011
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.011
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.011
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.011
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.011
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.011
|
|
|
|
dopamine receptor signaling pathway
|
GO:0007212 |
16 |
0.011
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.011
|
|
|
|
negative regulation of myoblast differentiation
|
GO:0045662 |
18 |
0.011
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.011
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.011
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.011
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.011
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.011
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.011
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.011
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.011
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.011
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.011
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.011
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.011
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.011
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.011
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.011
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.011
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.011
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.011
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.011
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.011
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.010
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.010
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.010
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.010
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.010
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.010
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.010
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.010
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.010
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.010
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.010
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.010
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.010
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.010
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.010
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.010
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.010
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.010
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.010
|
|
|
|
sensory perception of smell
|
GO:0007608 |
26 |
0.010
|
|
